BOULDER, CO, November 12, 2017 – AmideBio LLC, a privately-held biopharmaceutical company, announced today that Dr. David L. Snitman has joined its business advisory board. Dr. Snitman has extensive experience …

AmideBio LLC, a privately-held biopharmaceutical company,  announced today that it has closed a new private placement round of $764,000 of preferred equity  financing. The proceeds will be used to further …

AmideBio LLC, a biopharmaceutical company in Boulder that makes peptides used in research to discover therapies for diabetes, has received a $338,387 grant that it will use to further develop …